Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative medicines based on cancer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.62March 27, 2019 4:10 PM Publication Identifies Cyclin E as Key Resistance Pathway to Breast Cancer Treated by CDK4/6 Inhibitors and Thereby Amenable to Treatment by CYC065 CDK2/9 InhibitorMarch 25, 2019 7:01 AM